Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon as an adjunct to sevoflurane anesthesia in young children undergoing cardiac catheterization
2015-002329-20Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jul 2015
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of xenon and sevoflurane (2 arms), sponsored by UZ Leuven. Primary endpoint: Hemodynamic stability during the procedure. Started Jul 2015; status: completed.
02
Drugs
xenonsevoflurane
Beyond the preview
Go deeper on 2015-002329-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002329-20.